William Wijns, Non-executive director

Attention, ouverture dans une nouvelle fenêtre. PDFImprimerEnvoyer

William Wijns is co-founder of Cardio3 BioSciences and is the permanent representative of the Cardiovascular Center Aalst CVBA. Dr Wijns graduated in 1976 from the University of Louvain in Belgium where he trained as a cardiologist until 1981. He then joined the Thorax Center in Rotterdam where he was actively involved with the first applications of nuclear cardiology, thrombolysis and coronary dilatation. After spending 2 years as a Visiting Associate Professor of Radiological Sciences at UCLA, Dr Wijns returned to the University of Louvain in Brussels where he directed the cardiac PET programme and became Clinical Professor of Cardiology. His research focused on the regulation of coronary blood flow and cardiac metabolism in ischemic heart disease. Since 1994, Dr Wijns has been the co-Director of the Cardiovascular Center Aalst and active as an interventional cardiologist.

 

More recently, he has been involved with the clinical applications of non-invasive coronary angiography with the use of multislice computed tomography. He has authored over 300 publications in peer-reviewed journals and holds several positions in national and international professional and scientific organizations. Dr Wijns is also a Board member of the World Heart Federation and the European Society of Cardiology (Chairperson European Relations Committee 2008-2010). Since September 2006, he is President of EAPCI, the European Association for Percutaneous Cardiovascular Interventions.

 

Back

William Wijns, Non executive director – William Wijns, is co-founder of Cardio3 BioSciences and is the permanent representative of the Cardiovascular Center Aalst CVBA. Doctor William Wijns was graduated in 1976 from the University of Louvain in Belgium where he trained as a cardiologist until 1981. He then joined the Thorax Center in Rotterdam where he was actively involved with the first applications of nuclear cardiology, thrombolysis and coronary dilatation. After spending 2 years as a Visiting Associate Professor of Radiological Sciences at UCLA, Dr Wijns returned to the University of Louvain in Brussels where he directed the cardiac PET program and became Clinical Professor of Cardiology. His research focused on the regulation of coronary blood flow and cardiac metabolism in ischemic heart disease. Since 1994, Dr Wijns is the co-Director of the Cardiovascular Center Aalst and merely active as an interventional cardiologist. More recently, he has been involved with the clinical applications of non-invasive coronary angiography with the use of multislice computed tomography. He has authored over 300 publications in peer-reviewed journals and holds several positions in national and international professional and scientific organizations. Dr Wijns is a also Board member of the World Heart Federation and the European Society of Cardiology (Chairperson European Relations Committee 2008-2010). Since September 2006, he is President of EAPCI, the European Association for Percutaneous Cardiovascular Interventions.
© 2009 Cardio 3 Biosciences

A concept of Expansion